P588 Ustekinumab for the treatment of Crohn's disease patients with TNF antagonist induced psoriasis. Real life experience from a tertiary referral center through week 54
Kuehbacher, T., Abu Hashem, R., Langel, N., Schreiber, S., Drvarov, O.
Published in Journal of Crohn's and colitis (01.02.2017)
Published in Journal of Crohn's and colitis (01.02.2017)
Get full text
Journal Article
P03.06 Pattern of Ki67+expanding CD8+cytotoxic T cells in healthy tissues, inflammation and the cancer microenvironment
Möller, K, Lennartz, M, Abu-Hashem, R, Blessin, N C, Mandelkow, T, Bady, E, Hube-Magg, C, Simon, R, Sauter, G, Fraune, C, Clauditz, T S, Büscheck, F, Luebke, A M
Published in Journal for immunotherapy of cancer (01.10.2020)
Published in Journal for immunotherapy of cancer (01.10.2020)
Get full text
Journal Article
DOP073 Submucosal injection of the oligonucleotide STNM01 is able to induce clinical remission, mucosal healing and histological response in left-sided ulcerative colitis patients with moderate-to-severe disease
Atreya, R., Kühbacher, T., Waldner, M.J., Hirschmann, S., Drvarov, O., Abu Hashem, R., Maaser, C., Kucharzik, T., Dinter, J., Schramm, C., Mertens, J., Holler, B., Mössner, J., Suzuki, K., Yokoyama, J., Terai, S., Yoneyama, H., Asakura, H., Hibi, T., Neurath, M.F.
Published in Journal of Crohn's and colitis (01.02.2017)
Published in Journal of Crohn's and colitis (01.02.2017)
Get full text
Journal Article